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Abstract
Arginase, a manganese-dependent enzyme that widely distributed in almost all creatures, is a urea cycle enzyme that
catalyzes the hydrolysis of L-arginine to generate L-ornithine and urea. Compared with the well-studied arginases from
animals and yeast, only a few eubacterial arginases have been characterized, such as those from H. pylori and B. anthracis.
However, these enzymes used for arginase activity assay were all expressed with LB medium, as low concentration of Mn
2+
was detectable in the medium, protein obtained were partially Mn
2+ bonded, which may affect the results of arginase
activity assay. In the present study, H. pylori arginase (RocF) was expressed in a Mn
2+ and Co
2+ free minimal medium, the
resulting protein was purified through affinity and gel filtration chromatography and the apo-form of RocF was confirmed
by flame photometry analysis. Gel filtration indicates that the enzyme exists as monomer in solution, which was unique as
compared with homologous enzymes. Arginase activity assay revealed that apo-RocF had an acidic pH optimum of 6.4 and
exhibited metal preference of Co
2+.Ni
2+.Mn
2+. We also confirmed that heat-activation and reducing regents have
significant impact on arginase activity of RocF, and inhibits S-(2-boronoethyl)-L-Cysteine (BEC) and Nv-hydroxy-nor-Arginine
(nor-NOHA) inhibit the activity of RocF in a dose-dependent manner.
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Introduction
Helicobacter pylori (H. pylori), a gastric pathogen that infects more
than 50% of the world population, is the cause of gastritis and
peptic ulcers and a risk factor for gastric cancer [1,2]. It usually
causes chronic infection and persists for the life of the host and is
not eradicated despite a vigorous immune response was raised by
host immune system [3], suggesting that the bacterial reserve some
mechanisms for escaping from host immune response, such
mechanisms have been under extensive study and reported
elsewhere [4,5,6].
Arginase is a urea-cycle enzyme that catalyzes the hydrolysis of
L-arginine to yield L-ornithine and urea, and it is present in almost
all known life forms and plays a crucial role in nitrogen
metabolism [7,8]. In the gastric pathogen H. pylori, arginase is
encoded by rocF gene and the resulting protein RocF exhibits
extensive genotypic and phenotypic variation [9,10]. Recently,
RocF was identified to show some immunosuppressant properties
and is probably involved in the bacterium’s evasion of the host’s
immune system [11]. Firstly, RocF competes with host inducible
nitric oxide synthase for the common substrate L-arginine, thus
reduces the synthesis of NO, an important component of innate
immunity and an effective antimicrobial agent that is able to kill
the invading pathogens directly. Research indicates that arginase-
deficient bacteria are more sensitive to NO-dependent killing by
host macrophages, whereas the wild-type bacteria exhibited no
loss of survival [12,13]. Secondly, RocF is involved in inhibiting
human T cell proliferation and T cell CD3f expression, and thus
efficiently reduces host cellular immune response by contributing
to the inability of T cells. [14]. Finally, the product urea is utilized
by urease to generate ammonia and carbon dioxide, which helps
to neutralize the acidic environment of the stomach and thus
facilitate colonization by the bacterium [15]. These clue that RocF
could inhibit host innate defense and adaptive immune response
simultaneously to facilitate the pathogenesis of H. pylori, thus RocF
is considered to be a new virulence of H. pylori [11].
The arginase activity of RocF has been characterized by McGee
et al previously by using the enzyme expressed in LB medium and
purified by Ni-NTA affinity chromatography, the enzyme exhibit
an metal preference of Co
2+.Mn
2+.Ni
2+ and show optimal
activity at pH 6.1 [16]. They also noticed that the specific activity
of purified arginase varied in different elutions, owing to the partial
inhibition of enzyme activity at high concentration of imidazole.
Besides, in order to determine the crystal structure of RocF, we
have also expressed the protein in LB medium and purified it by
Ni-NTA affinity and gel filtration chromatography [17], the
resulting protein was partially Mn
2+ bounded as determined by
flame photometry analysis, the extra divalent ions would also affect
the determination of arginase activity of RocF. In order to
minimize the influence of imidazole and the extra Mn
2+ on
arginase activity assay, apo-RocF is required.
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26205In this paper, we have developed a Mn
2+ and Co
2+ free
minimum medium to express apo-form of RocF, the resulting
protein was first purified by Ni-NTA affinity chromatography and




2+ were not detected in the protein
as determined by flame photometry analysis, indicating apo-RocF
was obtained, the protein was used to determine the optimum of
divalent ions and pH value; the impact of heat-activation,
reducing agents and potent inhibitors on arginase activity of
apo-RocF were also studied.
Results and Discussion
Protein expression and purification
A minimum medium was chosen for the expression of apo-
RocF, the formation of the medium was listed in Table 1, Mn
2+
and Co
2+ were excluded of the medium as they were critical for
arginase activity [16,18,19,20], other metal ions such as Fe
2+ and
Mg
2+ that essential for bacterial normal growth were retained in
the medium. RocF was expressed at 37uC under the induction of
1 mM IPTG, SDS-PAGE of cell lysates showed a major protein
band of the expected 37 kDa size. RocF was expressed in the
soluble fraction and the level was about 10% of the total cellular
proteins, which was less than 20% of RocF expressed in LB
medium (data unreported). By virtue of the His6 tag at the C-
terminal of the protein, the sonicated supernatant was loaded onto
Ni-NTA column directly for affinity chromatography, SDS-PAGE
indicate that the eluate had a purity of about 90%, the eluate was
then concentrated and applied to gel filtration chromatography,
fractions corresponding to RocF monomer was pooled and
analyzed by SDS-PAGE, the purity was up to about 95%. The
protein was found to be highly unstable and will lost considerable
of its activity quickly, which was in consistence with the previous
report by McGee et al [16], the purified protein was stored at 4uC
and used for activity assay within 3 days to minimize lose of its
activity in the present study.
Oligomerization of apo-RocF
Gel filtration indicates that apo-RocF exists as monomer in
solution (Figure S1), which is in consistent with the former report
that RocF exists as a mixture of monomer and dimer with
monomer being the major form, and dimmer was undetectable
with salt concentrations higher than 100 mM [21]. This is strange
because only two different oligomeric states of arginase have been
reported so far. In general, the eukaryotic arginases tend to be
trimeric whereas the bacterial ones tend to be hexameric [22,23].
To explain the reason for the difference, the amino acid sequences
of several arginases including those from rat [24], homo-sapiens
[22,23], T. thermophilus, B. caldovelox [22,23]and H. pylori were
aligned with the online program ClusterW2 (http://www.ebi.ac.
uk/Tools/msa/clustalw2/), the structures of these arginases
except RocF were available at PDB. As shown in Figure 1, RocF
retains the three conserved characteristic domains including
GGDHS, SXDXDXDP and DAHXD that are critical for ions
binding and the catalytic process as other arginases [22,23].
However, an insertion of 13 residues (ESEEKAWQKLCSL) was
observed in the middle of the sequence of RocF, the function of
this domain was not clear for the moment. Besides, RocF exhibits
considerable differences in N and C-terminal sites and the C-
terminal sequence were thought to be essential for the oligomer-
ization of arginase. In brief, the C-terminal 14 residues in
eukaryotic arginases (Figure 1, green box) termed an ‘oligomer-
ization motif’ was essential for trimer formation [22,23].
Sequences alignment indicates that this motif was absent in
prokaryotes arginases, on the other hand, prokaryotes arginases
form hexamer by interactions of residues from the C-terminal
through salt bridges and hydrogen bonds [22,23]. However, RocF
was unique among all of these enzymes, it adopts a "KHSFARSY"
motif in the C-terminal which was not found in other prokaryotes
arginases and shows no similarity with the ‘oligomerization motif’,
we propose that this motif may responsible for the oligomeric
organization of RocF as monomer.
Protein determinations
Researches revealed that arginase is a binuclear manganese
metalloenzyme, each monomer was able to bind two manganeses
[22,23], however, some arginases can be activated by other
divalent metal ions such as cobalt and nickel, particularly, it was
reported that arginase from H. pylori and B. anthracis exhibit
optimal catalytic activity at the presence of Co
2+ and Ni
2+,
respectively [16,20], so we assume that the three dimensional
structure of RocF in complex with Co
2+ may undergo conforma-
tion switch as compared with RocF in complex with Mn
2+.I n
order to gain Co
2+ bounded RocF for structure studies, we have
tried to purify RocF expressed in LB medium by Co-NTA affinity
chromatography, however, the resulting protein was both Co
2+
and Mn
2+ bounded as determined by flame photometry analysis
(Table 2) , while Ni
2+ was undetectable. The ratio was 8:1 for
RocF and Co
2+ and 3.6:1 for RocF and Mn
2+, indicating that the
affinity between RocF and Mn
2+ was relatively higher than Co
2+
and Ni
2+. Based on these results, we propose that RocF was Mn
2+
bounded in vivo as other arginases. When the protein was purified
by Ni-NTA affinity chromatography, only Mn
2+ was detected in
the protein with a ratio of 1:1.8 (Table 2), these results revealed
that protein expressed in LB medium was already Mn
2+ bounded
and this will affect the results for arginase activity assay. The ratio
between Mn
2+ and RocF was nearly 1:2, obviously lower than the
saturation value of 2:1. These results indicate that these metal ions
bind RocF with low affinity, which was supported by the finding
that arginases will lose divalent metal ions during the process of
dialysis [25].
In order to obtain apo-RocF for arginase activity assay, we
developed a Mn
2+ and Co
2+ free minimum medium to express
RocF and the resulting protein was purified by Ni-NTA affinity
and gel filtration chromatography, these three kinds of metal ions
in the protein were also determined, as shown in table 2, the
concentration of these metal ions were not detectable as compared
with RocF, indicating that apo-RocF was obtained and this form
of the enzyme was used for arginase activity assay. Besides,
imidazole also has considerable impact on the colorimetric
development by L-ornithine. In this study, the protein eluated
from Ni-NTA was also used for arginase activity assay, however,
Table 1. The formation of the minimum medium used for
expression of apo-RocF.
Regents Concentration Regents Concentration
Na2HPO4 8 g CaCl2 0.3 mM
KH2PO4 4 g FeCl3 0.03 mM
Glucose 4 g H3BO3 0.03 mM
NH4Cl 0.5 g CuCl2 0.03 mM
NaCl 0.5 g Biotin 1 mg
MgSO4 1 mM Thiamin 1 mg
doi:10.1371/journal.pone.0026205.t001
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characteristic yellow color developed within a few minutes but
diminished after 1h, indicating that imidazole should be excluded
from the protein for accurate activity assay. In this study, gel
filtration chromatography was applied for further purification of
apo-RocF as well as desalting.
The concentration of the purified protein was determined by
BCA assay (Thermo Scientific PIERCEH) [26] according to the
protocol and adjusted to 0.05 mg ml
21 for arginase activity assay.
A standard curve was generated and used to determine the
concentration of L-ornithine in the reaction mixture, the R
2 value
was 0.9989 (Figure S2).
Optimal metal ions and pH of apo-RocF
The activity of the purified apo-RocF was measured at the
presence of different divalent metal ions at pH 3.0, 6.0 and 9.0, as
Figure 1. Alignment of amino acid sequences of RocF with homologous enzymes. Colored outlines indicate identical and similar amino
acid residues, respectively. Residues in the three blue boxes represent the three conserved domain that consider being important for ions binding
and the catalytic process. Residues in the red box were an insertion that only observed in RocF but not other arginases. Residues in the black box
revealed the difference in the N-terminal of aligned enzymes. Residues in the green box represent the domain termed ‘oligomerization motif’ that
exist in eukaryotic arginases, which was absent in T. thermophilus and B. caldovelox arginases but was substituted by a non-conserved motif in RocF.
doi:10.1371/journal.pone.0026205.g001
Table 2. Flame photometry analysis of divalent metal ions in RocF obtained in different medium and purified by different
methods.
Medium Method for purification RocF (mM) Co
2+ (mM) RocF: Co
2+ Ni
2+ (mM) RocF: Ni
2+ Mn
2+ (mM) RocF: Mn
2+
LB Co-NTA and gel filtration 146 18 8:1 ,1 - 41 3.6:1
LB Ni-NTA and gel filtration 122 ,1- ,1 - 66 1.8:1
Minimum Ni-NTA and gel filtration 74 ,1- ,1- ,1-
doi:10.1371/journal.pone.0026205.t002
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arginases, apo-RocF show optimal catalytic activity when heat-
activated with Co
2+, significantly higher than incubated with Ni
2+
and Mn
2+, the specific activity was slightly higher when heat-
activated with Ni
2+ as compared with Mn
2+. No arginase activity
was detected at the presence of other divalent ions. Obviously, the
highest activity appears at pH 6.0, which was in consistence with
the report that RocF had an acidic pH optimum [16]. Our data









2+ partially bounded RocF [16]. Apo-RocF also exhibit
considerable arginase activity at pH 9.0, which was half as that at
pH 6.0, no activity was detected at pH 3.0, probably due to
denature of the enzyme under acidic conditions. The fresh apo-
RocF yield a high arginase activity of nearly 900U, which was
nearly the same as the activity of B. anthracis arginase [20] but was
100 times higher than RocF reported previously [16], indicating
the extra imidazole and Mn
2+ have significantly impact on
arginase activity of RocF.
RocF was considered to be important for survival of H. pylori in
the acidic gastric environment [27]. In the present study, by
determination of arginase activity of apo-RocF at various pH value
revealed that it exhibit a pH optimum of 6.4 (Figure 3), which was
nearly the same as the report of 6.1 [16], this is unique because all
otherarginasescharacterizedhave aalkalinepHoptimumof9to11
[20,28], so we consider that the acid pH optimum of RocF may be
an adaptation to the acidic colonization environment of H. pylori.
Heat-activation was essential for arginase activity of
apo-RocF
Previous studies indicated that arginase activity significantly
increased after head-activation with metal ions at 55uC before
reaction [16,20]. In this study, apo-RocF was incubated with
CoCl2, MnCl2 and NiCl2 at 4uC, 37uC, 55uC and 70uC for
30 min and then used for activity assay. Remarkably, heat
treatment dramatically increased arginase activity in the presence
of these ions. When heat-activated at the existence of Co
2+, the
activity at 55uC was 2.5, 1.5 and 3 times higher than heat-
activated at 4uC, 37uC and 70uC, respectively. Similar results were
observed when heat-activated with Mn
2+ and Ni
2+ but the
difference was not so obviously (Figure 4). These results indicate
heat-activation is essential for arginase activity, probably by
promoting the binding of RocF with these ions. Lower activity was
observed at 70uC, maybe the enzyme is not stable as before or
even denatured at such a high temperature, thus resulting in a
lower activity.
Reducing agents significantly reduce arginase activity of
apo-RocF
Previous studies revealed that RocF is extremely sensitive to
reducing agents such as dithiothreitol (DTT) and 2-mercaptoeth-
anol (b-ME) and its activity could be inhibited by small dose of
these agents [16,29]. In this study, the impact of DTT and b-ME
on the activity of apo-RocF were also evaluated, various
concentration of these agents were added into the reaction
mixture before or after heat-activation at 55uC at the existence of
Co
2+, as shown in Figure 5, both DTT and b-ME have significant
influence on its activity. Obviously, RocF is more sensitive to DTT
Figure 2. Apo-RocF exhibits optimal catalytic activity at the
existence of cobalt in an acidic pH. Apo-RocF was first heat-
activated at the existence of different divalent metal ions for 30 min at
55uC and the arginase activity was measured at pH 3.0, 6.0 and 9.0 as
described in methods. Arginase activity was detectable when assayed
with CoCl2, MnCl2 and NiCl2 at pH 6.0 and 9.0, the highest activity was
observed at the present of Co
2+ at pH 6.0.
doi:10.1371/journal.pone.0026205.g002
Figure 3. Apo-RocF shows optimal catalytic activity at pH 6.4. Apo-RocF was heat-activated with CoCl2 at 55uC and then assayed for arginase
activity at 37uC for 60 min in arginase buffer at various pH values. Data are presented as mean arginase activity 6 standard deviation. A) Screen of
arginase activity of apo-RocF between pH3.0 to 9.0. B) Further Screen of arginase activity of apo-RocF between pH 5.1 to 7.9.
doi:10.1371/journal.pone.0026205.g003
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arginase activity when added into the reaction mixture before
heat-activation. When reducing agents were added before heat-
activation, the arginase activity of apo-RocF reduced dramatically
even the concentration of reducing agents was 5 mM, and arginase
activity reduced quickly as the concentration of reducing agents
increase, 30 mM of DTT and 300 mMo fb-ME will resulted in
completely loss of arginase activity, with 50% inhibitory
concentrations (IC50) of 10 mM and 30 mM, respectively.
However, when added after heat-activation, the activity of apo-
RocF was not affected even the concentration of DTT reached
20 mM, and 1 mM DTT is required for completely lost of arginase
activity, which was 30 times higher than added before incubation.
For b-ME, the activity began to reduce when the concentration
reached 100 mM, and the activity was still detectable even the
concentration reached 10 mM. Similar results were observed at
the present of Mn
2+ and Ni
2+ (data unreported). Compared with
the results reported previously, our results indicate that apo-RocF
was more sensitive to reducing agents. These difference further
confirmed that heat-activation at 55uC will significantly promote
the binding of metal ions with RocF.
As there are six cysteines in the amino acid sequence of RocF, it
was believed that disulphide bonds are critical for the catalysis
process and essential for the activity of the enzyme, and the
existence of a disulphide bond between Cys66 and Cys73 was
confirmed by mass spectrometric studies [30], so it was suggested
that reducing agents reducing the activity of RocF probably by
disturbing the formation of disulphide bonds. However, muta-
tional analysis shows that disulphide bonds are not important for
catalytic activity [29]. Further more, we have determined the three
dimensional structure of RocF and no disulphide bonds were
observed between these cysteines (to be published). Besides, we
have noticed that precipitation appeared as soon as these reducing
agents were added into apo-RocF. These results indicate that no
disulphide bonds was exist in RocF, and reducing agents
significantly reducing the activity probably by competes with the
enzyme for metal ions, as the later were important for the stability
and enzymatic catalytic process of RocF, this assumption was
supported by a former report [29].
BEC and nor-NOHA inhibit arginase activity of apo-RocF
in a dose-dependent manner
BEC and nor-NOHA are two L-arginine analogues that have
successfully co-crystallized with arginases from various species
[31,32,33], indicating that these chemicals may server as potent
inhibitors and are important candidates for novel anti-bacterial
drug development. In this study, the inhibitory effect of the two
chemicals on arginase activity of apo-RocF was assayed, as shown
in Figure 6, both BEC and nor-NOHA are able to inhibit RocF
activity in a dose-dependent manner. Notably, the highest
inhibitory effect was observed when heat- activated with Co
2+,
with 50% inhibitory concentrations (IC50) of 1 mM and 0.5 mM
for BEC and nor-NOHA, respectively, indicating that nor-NOHA
exhibit a higher affinity with RocF. However, the inhibitory effect
of these inhibitors was not significant as compared with reducing
agents, when the concentration of these chemicals reached
10 mM, the specific activity was still detectable. Similar results
Figure 4. Effect of heat-activation on arginase activity of apo-
RocF. Apo-RocF was heat- activated at 37uC, 55uC and 70uCo r
maintained on ice for 30 minutes at the presence of 5 mM CoCl2, MnCl2
or NiCl2, and then assayed with arginase buffer at pH 6.4 (buffered by
MES). Data are presented as mean arginase activity 6 standard
deviation.
doi:10.1371/journal.pone.0026205.g004
Figure 5. Apo-RocF is extremely sensitive to reducing agents. Various concentrations of reducing agents DTT or b-ME were added into the
reaction mixture before (A) or after (B) heat-activation with CoCl2. Reducing agents were replaced with sterile water in control tubes. The 50%
inhibitory concentration (IC50) was determined from the graph.
doi:10.1371/journal.pone.0026205.g005
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2+ and Ni
2+.
Interestingly, the inhibitory effect of the two chemicals on apo-
RocF activity can be divided into two parts, when the
concentration of BEC were lower than 5 mM, the activity of
RocF decreased quickly as the concentration of BEC increase;
however, when the concentration of BEC were higher than 5 mM,
the activity of RocF decreased in a lower speed. For nor-NOHA,
the corresponding concentration was 0.5 mM, obviously lower
than BEC. These results indicate that nor-NOHA and its
analogues are more effective to serve as potent inhibitors for
RocF than BEC.
Materials and Methods
Cloning and expression of apo-RocF
The rocF gene (NCBI-Gene ID: 899897) encoding H. pylori
arginase RocF was amplified by PCR from H. pylori strain 26695
genomic DNA and cloned via introduced NdeI/XhoI restriction
sites into the pET22b vector (Novagen) resulting in the
recombinant plasmid pET22b-rocF as described previously [17].
Apo-RocF was obtained by expression of RocF in a Mn
2+ and
Co
2+ free minimal medium. In brief, E. coli strain BL21 (DE3)
(Novagen) competent cells transformed with the recombinant
plasmid pET22b-rocF were first grown in LB medium containing
100 mg ml
21 ampicillin at 37uC until the OD600 of the culture
reached 0.8. The cells were harvested by low-speed centrifugation,
resuspended and washed twice in minimal medium, cells was then
transferred to minimal medium containing 100 mg ml
21 ampicil-
lin and incubated for 2 h at 37uC, isopropyl b-D-1-thiogalacto-
pyranoside (IPTG) was then added to the culture at a final
concentration of 1 mM to induce the expression of the
recombinant protein at 37uC for 3 h. Cells was harvested by
centrifugation at 4,000 rpm for 30 min at 4uC.
Purification and determination of apo-RocF
Cell pellets were resuspended in 15 ml lysis buffer (50 mM
NaH2PO4 pH 8.0, 300 mM NaCl and 10 mM imidazole) and
sonicated on ice. The lysate was centrifuged at 16,000 rpm for
30 min at 4uC. The supernatant was then loaded onto a Ni-NTA
column (Novagen) equilibrated with the lysis buffer. After washing
with the washing buffer (50 mM NaH2PO4 pH 8.0, 300 mM
NaCl and 25 mM imidazole) to remove unbound fractions, the
elution buffer (50 mM NaH2PO4 pH 8.0, 300 mM NaCl and
250 mM imidazole) was applied. The eluate containing the
recombinant protein RocF was concentrated to about 1.0 ml
and then applied to a Hiload16/60 Superdex200 prep-grade gel
filtration column (Amersham Biosciences) equilibrated with
20 mM Tris-HCl, pH 7.5 and 150 mM NaCl. The peak fractions
corresponding to the recombinant protein were pooled and
analyzed by SDS-PAGE.




2+) in the protein were determined by flame
photometry in Tsinghua University. The concentration of the
protein was determined by BCA method by using BSA as a
standard [26]. The oligomeric state of the enzyme was determined




The arginase assay was carried out spectrophotometrically by
measuring the formation of L-ornithine at 515 nm with ninhydrin.
Protein sample of apo-RocF after purification was diluted to
0.05 mg ml
21 with 20 mM Tris-HCl pH 7.5 and 150 mM NaCl.
The sample (25 ml) was added to 25 mL of 10 mM of various
divalent metal ions (final concentration of 5 mM) or 25 ml of sterile
water as no metal ion negative control. The mixture were heat-
activated at 55uC or were maintained on ice for 30 min. 200 mlo f
buffered 10 mM L-arginine (arginine buffer) was then added, and
the mixtures were incubated at 37uC for 1 h. The reaction was
stopped by the addition of 750 ml of acetic acid, and the color was
then developed by the addition of 250 ml of ninhydrin (4 mg ml
21)
at 95uC for 1 h. The concentration of L-ornithine was measured
spectrophotometrically at 515 nm in 1.5 ml cuvettes. Represen-
tative data were normalized for protein and are presented as
specific activity in nmol L-ornithine/min/mg protein 6 standard
deviation with a minimum of two experiments conducted in
Figure 6. Inhibitors BEC (A) and nor-NOHA (B) inhibit argianse activity of apo-RocF in a dose-dependent manner. Apo-RocF was first
heat-activated at 55uC at the existence of CoCl2, MnCl2, or NiCl2, arginase activity was then assay with arginase buffer at pH 6.4 contain different
concentrations of inhibitors. Inhibitors were replaced with sterile water in control tubes. The 50% inhibitory concentration (IC50) was determined
from the graph.
doi:10.1371/journal.pone.0026205.g006
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to measure the concentration of L-ornithine in the reaction
mixture, the method was the same as argianse activity assay, and
the concentration of L-ornithine in the 1.25 ml reaction mixture
was 0, 20, 40, 60, 80 and 100 mM, respectively.
Metal ions, pH and temperature optimum
To determinate the metal ions preference of apo-RocF, the
activity of the purified RocF was measured at the existence of
different divalent metal ions (CoCl2, MnCl2, NiCl2, CuSO4,
CaCl2, ZnCl2, MgCl2, FeSO4) at pH 3.0, 6.0 and 9.0, respectively.
To determine pH optimum, buffers of different pH including citric
acid (pH 3.0), sodium acetate (pH 4.0), sodium citrate tribasic
dihydrate (pH 5.0), MES (pH 6.0), HEPES (pH 7.0), Tris (pH 8.0)
and Capso (pH 9.0) were obtained by addition of concentrated
HCl or 10 M NaOH after the addition of arginine (10 mM). To
confirm the effect of heat-activation on arginase activity of apo-
RocF, the purified protein was incubated with equal volume of
CoCl2, MnCl2 and NiCl2 (25 mL) at 4uC, 37uC, 55uC and 70uC
for 30 min and then used for arginase activity assay.
Effect of reducing agents on arginase activity of
apo-RocF
To determine the impact of reducing agents on arginase activity
of apo-RocF, different concentrations of DTT or b-ME were
added to the reaction mixture before or after incubation at 55uCa t
the presence of Co
2+, while sterile water was served as positive
control. The concentration of RocF, arginine, Co
2+ and the total
reaction volume were the same as previously.
Effect of inhibitors nor-NOHA and BEC on arginase
activity of apo-RocF




2+ at 55uC, arginase buffer containing different
concentrations (0.1 mM, 0.5 mM, 1 mM, 5 mM and 10 mM) of
two inhibitors, nor-NOHA and BEC, were then added into the
reaction mixture and the inhibitory effect on arginase activity of
apo-RocF was evaluated. The concentration of RocF, arginine,
divalent ions and the total reaction volume were not changed, and
the inhibitor free aiginine buffer was used as positive control.
Supporting Information
Figure S1 RocF exists as monomer in solution. Gel-
filtration chromatography (Superdex
TM 200 10/300GL) for apo-
RocF in 20 mM Tris-HCl, pH 7.5 and 150 mM NaCl, apo-RocF
exists as monomer according to the position of the peak.
(TIF)
Figure S2 The standard curve generated for determi-
nation the concentration of L- ornithine.
(TIF)
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